Market Place
Sourcing Support
Zydus Gets USFDA Nod For Bosentan 32mg Oral Suspension
19 Feb 2026 //
INDPHARMAPOST
Generic Industry Opposes Fee Breaks for U.S. Firms
19 Feb 2026 //
RAPS
Dr Reddy`s Readies Day-1 Launch Of Semaglutide Generic
18 Feb 2026 //
ECONOMICTIMES
Patent Growth And Lawsuits Deter Generic Pharma Rivals
18 Feb 2026 //
BIOSPACE
Axsome Pharma Resolves SUNOSI Patent Dispute With Alkem Labs
17 Feb 2026 //
GLOBENEWSWIRE
NATCO Receives CDSCO Approval For Semaglutide In India
15 Feb 2026 //
INDPHARMAPOST
Zydus Gets USFDA Nod For Ammonium Lactate Cream 12%
15 Feb 2026 //
INDPHARMAPOST
Biocon Targets Growth With Generic Weight-Loss Drugs
13 Feb 2026 //
REUTERS
Akums Receives First UK MHRA Approval For Rivaroxaban
13 Feb 2026 //
EXPRESSPHARMA
Difgen Pharma Secures FDA Approval for Fluorometholone Eye Drops
13 Feb 2026 //
PR NEWSWIRE
Warburg-Mubadala Team Up, Emerge As Frontrunner For Encube
11 Feb 2026 //
ECONOMICTIMES
GSK, Teva Quietly Settle Coreg `s Label` Dispute
11 Feb 2026 //
FIERCE PHARMA
SFDA Approves OneSource`s Generic Semaglutide in Saudi Arabia
11 Feb 2026 //
EXPRESSPHARMA
Hims Quits On Obesity Pill After Legal, Regulatory Heat
09 Feb 2026 //
FIERCE PHARMA
SQ Innovation Launches Lasix® ONYU With U.S. Pharma Distributors
09 Feb 2026 //
PR NEWSWIRE
Pharma Companies Advocate For Policy Clarity To Safeguard
08 Feb 2026 //
ECONOMICTIMES
Alembic Pharma Receives USFDA Approval For Generic Parkinson`s
07 Feb 2026 //
INDPHARMAPOST
Pharma Companies Advocate For Policy Clarity To Safeguard
07 Feb 2026 //
ECONOMICTIMES
Makary Criticizes `Illegal Copycat Drugs` Amid Hims` Compounded
06 Feb 2026 //
BIOSPACE
FDA Proposes Waiving GDUFA Fees for Domestic Facilities
06 Feb 2026 //
RAPS
Bridgebio Shares Slide On Pfizer`s ATTR Patent Withdrawal
06 Feb 2026 //
FIERCE PHARMA
Alembic Pharma Receives USFDA Approval For Generic Parkinson`s
06 Feb 2026 //
ECONOMICTIMES
Zydus Receives USFDA Tentative Approval For Dapagliflozin Tablets
05 Feb 2026 //
EXPRESSPHARMA
Lupin Introduces Topiramate Extended-Release Capsules In US
05 Feb 2026 //
PRESS RELEASE
Hims & Hers Plans To Launch $49 Copy Of Wegovy Pill
05 Feb 2026 //
FIERCE PHARMA
NATCO Receives Fda`s Tentative Approval For Erdafitinib Tablets
04 Feb 2026 //
INDPHARMAPOST
National Pharmaceutical Pricing Authority Sets Retail Prices
03 Feb 2026 //
PHARMABIZ
Lupin Launches Dasatinib Tablets In The United States
02 Feb 2026 //
PRESS RELEASE
Indoco Remedies Gets USFDA Nod To Sell Generic Epilepsy Medicine
30 Jan 2026 //
ECONOMICTIMES
U.S. FDA Accepts Transpire Bio`s ANDA for Generic Trelegy Filing
27 Jan 2026 //
GLOBENEWSWIRE
Alembic Gets USFDA Nod For Difluprednate Ophthalmic Emulsion
27 Jan 2026 //
EXPRESSPHARMA
MNC`s Cancer Drug Patent Rejected, Allowing Generics Entry
23 Jan 2026 //
ECONOMICTIMES
Sun Pharma Receives DCGI Approval For Generic Semaglutide
23 Jan 2026 //
ECONOMICTIMES
Aspire Biopharma Files Patent for Sublingual Generic Xanax(R)
20 Jan 2026 //
PHARMIWEB
FDA Confirms Para IV Patent Litigation for Emrosi
19 Jan 2026 //
FDA
FDA Confirms Para IV Patent Litigation for Tadliq
19 Jan 2026 //
FDA
FDA Confirms Para IV Patent Litigation for Scemblix
19 Jan 2026 //
FDA
SEC Recommends Three Firms For Semaglutide Formulations
19 Jan 2026 //
PHARMABIZ
Zydus Lifesciences Gets USFDA Nod For Generic Blood Disorder Drug
17 Jan 2026 //
ECONOMICTIMES
Zydus Receives Final Approval From USFDA For Eltrombopag Tablets
16 Jan 2026 //
INDPHARMAPOST
Apiject Opens U.S. Generic Injectable Facility in Apex, NC
16 Jan 2026 //
PR NEWSWIRE
Dr. Reddy’s Announces First-to-Market Launch of Olopatadine HCl
14 Jan 2026 //
PRESS RELEASE
Altanine`s Outlook on Generics and Value-Added Formulations
14 Jan 2026 //
GLOBENEWSWIRE
Bionpharma Gets USFDA Nod For Etravirine Tablets With Steerlife
13 Jan 2026 //
PR NEWSWIRE
Allos Secures $5M For Causal AI In Drug Reformulation
12 Jan 2026 //
PR NEWSWIRE
ChemWerth Appoints New GSM to Expand India Generic API Reach
12 Jan 2026 //
PRESS RELEASE
Biocon Arm Gets USFDA Nod For Generic Everolimus Tablets
12 Jan 2026 //
ECONOMICTIMES
Alembic Announces USFDA Tentative Approval For Bosutinib Tablets
12 Jan 2026 //
INDPHARMAPOST
FDA Confirms Para IV Patent Litigation for Livtencity
09 Jan 2026 //
FDA
FDA Confirms Para IV Patent Litigation for Brukinsa
09 Jan 2026 //
FDA
Granules India Secures USFDA Tentative Approval For gDYANAVEL XR
08 Jan 2026 //
PRESS RELEASE
Gland Pharma Wins OTC Approval for Olopatadine Eye Solution
08 Jan 2026 //
MEDICALDIALOGUE
RVL Pharma: Santen Gets Japan Approval For UPNEEQ Mini
08 Jan 2026 //
PR NEWSWIRE
Earendil Labs Announces Strategic Collaboration with Sanofi
06 Jan 2026 //
PR NEWSWIRE
HC Seeks Novo Nordisk`s Reply On Natco Plea To Revoke Patent
06 Jan 2026 //
ECONOMICTIMES
Indian Pharma Companies` New Drug Filings Hit 20-Year Low: Nomura
06 Jan 2026 //
BUSINESS STD
Pharmexil Holds Key Talks On India`s Generic Pharma Export
06 Jan 2026 //
EXPRESSPHARMA
CivicaScript Launches Low-Cost Insulin Biosimilar in US
05 Jan 2026 //
PR NEWSWIRE
Scinopharm Gets FDA Nod For Glatiramer Acetate Injection
05 Jan 2026 //
PR NEWSWIRE
Sun Pharma Eyes Obesity Drugs as Growth Driver
28 Dec 2025 //
ECONOMICTIMES
